RFG Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$415K Buy
358
+4
+1% +$4.72K 0.09% 53
2026
Q2
$425K Buy
354
+2
+0.6% +$2.04K 0.09% 55
2026
Q1
$324K Buy
352
+5
+1% +$5.07K 0.08% 53
2025
Q4
$373K Buy
347
+4
+1% +$3.82K 0.09% 47
2025
Q3
$262K Buy
+343
New +$255K 0.07% 55
2024
Q4
– Sell
-343
Closed -$304K – 59
2024
Q3
$304K Buy
343
+19
+6% +$17.1K 0.11% 43
2024
Q2
$294K Buy
324
+25
+8% +$20K 0.11% 42
2024
Q1
$233K Buy
+299
New +$213K 0.1% 39

Other funds holding LLY

RFG Holdings's LLY Position: Q3 2026 in Review

RFG Holdings increased its Eli Lilly (LLY) stake by 1.1% in Q3 2026, buying an estimated $4.72K and bringing the position to 358 shares worth $415K. The position accounts for 0.09% of the portfolio, ranked #53.

RFG Holdings first reported a position in LLY in Q1 2024 and has held it in 8 quarters since. The position peaked at $425K in Q2 2026. 3,642 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • RFG Holdings held 358 shares of Eli Lilly worth $415K as of Q3 2026.
  • RFG Holdings bought 4 Eli Lilly shares in Q3 2026, an estimated $4.72K.
  • Eli Lilly made up 0.09% of RFG Holdings's portfolio in Q3 2026, its #53 holding.
  • RFG Holdings first reported a position in Eli Lilly in Q1 2024 and has held it in 8 quarters since.
  • RFG Holdings's Eli Lilly position peaked at $425K in Q2 2026.
  • 3,642 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on RFG Holdings's 13F filing for Q3 2026, filed 30 Oct 2026.